BofA upgrades Sylvamo stock rating on European divestiture plan

BofA Securities upgraded Sylvamo to Buy from Neutral and set a $42 price target, citing its positive view of third-quarter results and potential value from divesting the European business. Sylvamo reported adjusted EPS of $1.33 versus $1.22 consensus, but revenue of $645 million missed the $835.43 million estimate and declined 3% year over year. The proposed European-business sale covers the Saillat and Nymolla mills and related operations; Sylvamo would retain the right to 20% of future distributions, with closing targeted by the end of Q1 2027. The article also cites a 5.44% dividend yield and management share buybacks.

Analysis

The equity case hinges less on the headline “divestiture” than on what Sylvamo receives and what earnings remain: the stated terms describe a transfer with agreed working capital and cash plus 20% of future distributions, not an identified upfront cash payment. That limits any near-term balance-sheet or capital-return uplift; the retained participation also leaves exposure to the European business without control. The transaction is not yet definitive, requires employee consultations, and is targeted to close in 2027, so execution and timing risk are material.

The EPS beat alongside a revenue miss is not enough to establish improving underlying demand. Because Europe is now treated as discontinued operations, verify that consensus and year-over-year revenue comparisons use the same continuing-operations scope, then focus on continuing-operations operating cash flow, volumes/pricing, and dividend coverage. The cited third-party fair value and analyst target are not independent evidence of realizable value.

Near term, the main catalysts are clarification of post-Europe earnings/cash generation and a definitive sale agreement; structural upside depends on whether the remaining business can sustain cash returns after Europe exits. The contrarian risk is that investors price the transaction as a clean monetization when value is contingent on future distributions and a distant close. No implication for BAC follows from BofA Securities’ rating.

Key Decisions for Investors

• Keep SLVM on a conditional, modest long-watchlist rather than buying solely on the rating change. Reassess after confirming comparable continuing-operations revenue, cash flow, and dividend coverage; the dividend yield is not a floor if the post-sale cash profile weakens.
• Treat a definitive agreement with unchanged economics and a credible transition plan as the 1–3 month validation catalyst. Reduce or avoid exposure if consultations delay the agreement, consideration changes materially, or management cannot explain stranded costs and retained obligations.
• For the 6–18 month thesis, monitor continuing-operations volumes/pricing, operating cash flow, and actual distributions from the European business. Falsify the value-unlock thesis if cash generation cannot support stated capital returns without Europe or if the retained 20% produces no meaningful distributions.
• Do not infer an actionable view on BAC: BofA Securities is the analyst source, not evidence about Bank of America Corporation’s fundamentals.